Radioimmunotherapy for Model B Cell Malignancies Using 90y-Labeled Anti-Cd19 and Anti-Cd20 Monoclonal Antibodies

Leukemia - United Kingdom
doi 10.1038/sj.leu.2402320
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radioimmunotherapy of Prostate Cancer Using 90y- And 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity

Clinical Cancer Research
Cancer ResearchOncology
2005English

Evaluation of Efficacy of Radioimmunotherapy With 90y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models

PLoS ONE
Multidisciplinary
2015English

90y-Labeled Anti-Robo1 Monoclonal Antibody Exhibits Antitumor Activity Against Small Cell Lung Cancer Xenografts

PLoS ONE
Multidisciplinary
2015English

Therapy of Advanced B-Lymphoma Xenografts With a Combination of 90y-Anti-Cd22 IgG (Epratuzumab) and Unlabeled Anti-Cd20 IgG (Veltuzumab)

Clinical Cancer Research
Cancer ResearchOncology
2008English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Characterization of Novel Murine Anti-Cd20 Monoclonal Antibodies and Their Comparison to 2B8 and C2B8 (Rituximab)

International Journal of Oncology
Cancer ResearchOncology
2007English

Radioimmunotherapy of Infection With 213Bi-Labeled Antibodies

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2008English

213Bi Radioimmunotherapy With an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Bismuth-213 Radioimmunotherapy With C595 Anti–MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy